Great team but long working hours - In House CRA 2seventy bio Employee Review

Great management, competitive pay, mission driven

Long hours, limited portfolio, lean teams

Innovative science; great location, pay, and solid benefits; committed and talented co-workers who truly wanted to develop therapies to give TIME back to patients' lives.

Meek, incompetent, and quite frankly, self-serving disingenuous management was what led to the downfall of 2seventy. Obfuscating to employees about the actual financial status of the company whilst repeating over and over again "PLENTY OF CASH INTO 2025!" in all-hands meetings. Reckless spending in scale (in house manufacturing) or spendthrift (over paying exec tech consultants, overpriced murals and events). The CEO really wanted to continue the culture and innovation that bluebirdbio (which 2seventy spun off of) had built into a 9 trillion dollar darling of Wall St... but like the failures at bluebird, management thought too big while not taking care of the small things that mattered (which led to attrition... and him blaming those who left, not on himself)... despite giving off the guise of "transparency" with employees... or themselves (except for the insiders who cashed out their stock before it tanked, like they did at bbb). After 2 rounds of layoffs and investor revolt, 2seventy sold off operations for pennies on the dollar to BP, and eventually curbed (the rest of what was left) to heel to BMS as the CEO and the rest of management walked away with golden parachutes. Many in the industry unfortunately know this tale too well these days during this bear market and rough macro investing environment. The motto, "it's all about TIME" became a self-fulfilling prophecy... as the company ran out of it (and money). I saw the best bio tech had to offer while here... but unfortunately, I also saw the worst.